Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension

FEBS Letters

Volumn 542, Issue 1-3, 2003, Pages 27-31

  Moreno, María U ^a   San José, Gorka ^a   Orbe, Josune ^a   Páramo, José A ^a,b   Beloqui, Oscar ^b   Díez, Javier ^a,b   Zalba, Guillermo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Hypertension; NAD(P)H oxidase; Polymorphism; Promoter

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ALLELE; ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVATION; FEMALE; GENE; GENE LOCATION; GENETIC MARKER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MUTAGENESIS; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX;

EID: 0038363762     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00331-4     Document Type: Article

References (22)

1. Cross A.R., Jones O.T.G. Biochim. Biophys. Acta. 1057:1991;281-298.
2. Leusen J.H.W., Verhoeven A.J., Roos D. J. Lab. Clin. Med. 128:1996;461-476.
3. DeLeo F.R., Quinn M.T. J. Leukoc. Biol. 60:1996;677-691.
4. Parkos C.A., Allen R.A., Conchrane C.G., Jesaitis A.J. J. Clin. Invest. 80:1987;732-742.
5. Mohazzab K.M., Kaminski P.M., Wolin M.S. Am. J. Physiol. 266:1994;H2568-H2572.
6. Pagano P., Ito Y., Tornheim K., Gallop P., Tauber A., Cohen R. Am. J. Physiol. 268:1995;H2274-H2280.
7. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. J. Clin. Invest. 97:1996;1916-1923.
8. Griendling K.K., Sorescu D., Ushio-Fukai M. Circ. Res. 86:2000;494-501.
9. Bouloumie A., Bauersachs J., Linz W., Scholkens B.A., Wiemer G., Fleming I., Busse R. Hypertension. 30:1997;934-941.
10. Panza J.A., Quyyumi A.A., Brush Jr.J.E., Epstein S.E. New Engl. J. Med. 323:1990;22-27.
11. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., Griendling K.K. J. Biol. Chem. 271:1996;23317-23321.
12. Zalba G., Beaumont F.J., San José G., Fortuño A., Fortuño M.A., Etayo J.C., Díez J. Hypertension. 35:2000;1055-1061.
13. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q.I.V., Taylor W.R., Harrison D.G., de Leon H., Wilcox J.N., Griendling K.K. Circ. Res. 80:1997;45-51.
14. Dinauer M.C., Pierce E.A., Bruns G.A.P., Curnutte J.T., Orkin S.H. J. Clin. Invest. 86:1990;1729-1737.
15. Porter C.D., Parkar M.H., Kinnon C. Hum. Mutat. 7:1996;374.
16. de Boer M., de Klein A., Hossle J.P., Seger R., Corbeel L., Weening R.S., Roos D. Am. J. Hum. Genet. 51:1992;1127-1135.
17. Hossle J.P., de Boer M., Seger R.A., Roos D. Hum. Genet. 93:1994;437-442.
18. Zalba G., San José G., Beaumont F.J., Fortuño M.A., Fortuño A., Díez J. Circ. Res. 88:2001;217-222.
19. Fortuño A., Muñiz P., Ravassa S., Rodríguez J.A., Fortuño M.A., Zalba G., Díez J. Hypertension. 34:1999;138-143.
20. Zalba G., San Jose G., Moreno M.U., Fortuño M.A., Fortuño A., Beaumont F.J., Diez J. Hypertension. 38:2001;1395-1399.
21. Sagar S., Kallo I.J., Kaul N., Ganguly N.K., Sharma B.K. Mol. Cell. Biochem. 111:1992;103-108.
22. Mehta J.L., Lopez L.M., Chen L., Cox O.E. Am. J. Cardiol. 74:1994;901-905.